Beckman Coulter acquires nucleic acid technology firm:
This article was originally published in Clinica
Executive Summary
Beckman Coulter has agreed to pay $100m, plus up to $40m in contingent payments until 2007, to acquire Agencourt Bioscience, a specialist in technology for the isolation and purification of RNA and DNA that reported sales of around $27m in 2004. Beckman Coulter says it will use Beverly, Massachusetts-based Agencourt's solid phase reversible immobilisation technology in its automated sample preparation systems for molecular testing and biomedical research. The acquired business will become a centre of excellence for nucleic acid science within Beckman Coulter's biomedical research division.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.